Utilizing Tear Fluid Biomarkers and Machine Learning for Early Identification of Keratoconus - Top-Institutions - MDSpire

Utilizing Tear Fluid Biomarkers and Machine Learning for Early Identification of Keratoconus

  • By

  • Yijun Lin

  • Yao Yao

  • Xiaocui Miao

  • Shumin Tang

  • Libin Huang

  • October 31, 2025

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Corneal Disease
    • Biomedical Informatics

  • #2

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease
    • Translational Research

  • #3

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Corneal and External Disease
    • Biomedical Engineering

  • #4

    University of California, San Francisco (UCSF) Department of Ophthalmology
    University of California, San Francisco (UCSF) Department of Ophthalmology

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Corneal Disease
    • Computational Medicine

  • #5

    Singapore National Eye Centre
    Singapore National Eye Centre

    Singapore

    Key Differentiators

    • Ophthalmology
    • Corneal Research
    • Biomedical Informatics

Original Source(s)

Utilizing Tear Fluid Biomarkers and Machine Learning for Early Identification of Keratoconus

  • by Yijun Lin, Yao Yao, Xiaocui Miao, Shumin Tang, Libin Huang

  • October 31, 2025

Related Content

Amazing Advancements in Anterior Segment Diagnostics

The latest on anterior segment OCT, corneal tomography, and confocal microscopy,

Personalizing Corneal Cross-Linking

How tailored approaches to CXL are transforming how we treat keratoconus and other corneal ectasias

A Chat with Bernie Iliakis of CorneaGen

Bernie Iliakis, president and CEO of CorneaGen, discusses the growing momentum of CTAK to treat keratoconus, how the company is meeting the growing demand for DMEK and DSAEK tissue processing, and more.

  • November 1, 2025

  • 4 min